The newly approved device delivers a pre‑set 7.2 mg once weekly maintenance dose of semaglutide in a single injection. Previously, the 7.2 mg dose was administered by taking three 2.4 mg injections ...

The drug delivery devices market offers opportunities in self-administration, home healthcare, and biologics due to rising chronic diseases. North America dominates this growing market with advanced ...

Now, cops in New Jersey may be allowed to carry life-saving EpiPens, under a bill sponsored by Sen. Declan O'Scanlon that ...

Australia's drug delivery devices market sees growth opportunities in addressing chronic illnesses with innovations like smart auto-injectors, AI wearables, and microneedle patchesDublin, April 07, ...

The new offering combines primary care, personalized treatment plans and transparent medication costs to help patients ...

New Mexico Attorney General Raúl Torrez said the state reached a $2.25 million settlement over claims a pharmaceutical ...

The company is deploying agents to audit model use, monitor device health, and accelerate engineering, even as it warns that ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the most undervalued biotech stocks to buy right now. Halozyme ...

New Mexico Attorney General Raúl Torrez announced that the State of New Mexico has reached a $2.25 million settlement with ...

About neffy® neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in adults and children who weigh 33 lbs. or greater. INDICATION AND IMPORTANT SAFETY ...

On April 13, Mizuho lowered its price recommendation on Embecta Corp. (NASDAQ:EMBC) to $12 from $14. It reiterated a Neutral ...

Six to seven years ago, a billion dollars recruitment and expansion project coming to North Carolina wasn’t new, says the CEO ...